Netherlands· NL-9e537b2c1d11
Ganirelix Gedeon Richter 0,25 mg/0,5 ml oplossing voor injectie in voorgevulde spuit
A ganirelix product containing ganirelixacetaat, registered in Netherlands by Gedeon Richter Plc.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ganirelix is registered in 17 of 19 countries.
Countries holding a registration under ATC H01CC01 (ganirelix), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Ganirelix · ATC H01CC01
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- GANIRELIXACETAAT
- Manufacturer
- Gedeon Richter Plc.
- Country
- Netherlands (NL)
- ATC code
- H01CC01
- ATC class
- Ganirelix
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/22/1658
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
7 interactions on record for ganirelix.
Graded by severity as the source publishes them — 7 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ganirelix · interactions on record
7 records
- 7 moderate
Most severe, free to view
- Chorionic gonadotrophinG03GA01moderate
- Menotropin HMGG03GA02moderate
- UrofollitropinG03GA04moderate
- GonadorelinH01CA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ganirelix in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFyremadelFerring Pharmaceuticals Inc.
- FranceFYREMADEL 0,25 mg/0,5 mL, solution injectable en seringue pré-remplieSUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- IrelandGanirelix Gedeon Richter 0.25 mg/0.5 mL solution for injection in pre-filled syringeChemical Works Of Gedeon Richter PLC
- FinlandFyremadelSun Pharmaceutical Industries Europe B.V.
- SpainASTARTE 0,25 MG/0,5 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGGp Pharm S.A.
- CzechiaGANIRELIX GEDEON RICHTERGedeon Richter Plc., Budapešť
- United KingdomFyremadel 250micrograms/0.5ml solution for injection pre-filled syringesFerring Pharmaceuticals Ltd
- SwitzerlandGanirelix Labatec 0,25 mg, solution injectable en seringue préremplieLabatec Pharma SA
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Ganirelix Astro, Ganirelix Theramex
- Belgium · Fyremadel, Ovamex
- Bulgaria · Ganirelix Theramex
- Czechia · Fyremadel
- Germany · Fyremadel, Ganiran
- Denmark · Fyremadel, Ganirelix Orifarm
- Estonia · Ganirelix Theramex
- Spain · Astarté, Fyremadel
- Finland · Fyremadel, Ganirelix Orifarm
- France · Fyremadel, Ganirelix Eg
- United Kingdom (Northern Ireland) · Fyremadel
- Greece · Fyremadel, Ovamex
- Croatia · Ganireliks Theramex
- Hungary · Ganirelix Theramex
- Iceland · Ganirelix, Ganirelix Gedeon Richter
- Italy · Fyremadel, Ovamex
- Liechtenstein · Ganirelix, Ganirelix Gedeon Richter
- Lithuania · Ganirelix Theramex
- Latvia · Ganirelix Theramex
- Norway · Fyremadel, Ganirelix
- Poland · Fyremadel, Ovamex
- Portugal · Astarté, Fyremadel
- Sweden · Fyremadel, Ganirelix Orifarm
- Slovenia · Ganireliks Theramex
- Slovakia · Fyremadel, Ganirelix Theramex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d42e4492-d24b-481a-8f85-510989418181 GET /v1/drugs/d42e4492-d24b-481a-8f85-510989418181?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/ganirelix-gedeon-richter-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Ganirelix",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128100",
"excipients": [
"AZIJNZUUR (E 260), GECONCENTREERD",
"MANNITOL (D-) (E 421)",
"NATRIUMHYDROXIDE (E 524)",
"WATER VOOR INJECTIE"
],
"substances": [
"GANIRELIXACETAAT"
],
"leaflet_url": null,
"authorised_at": "2022/07/15",
"procedure_number": "EMEA/H/C/005641",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1658",
"additional_monitoring": "N"
}See everything about ganirelix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.